Earlier studies have found that variants in the SPFH domain of the ERLIN2 gene could cause HSP or ALS [14–16], but the heterozygous pathogenic mode is not clear, and the molecular mechanism remains to be elucidated. This evidence concerns the gene ERLIN2 and hereditary spastic paraplegia.